BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31959758)

  • 1. Predictive Risk-scoring Model For Central Lymph Node Metastasis and Predictors of Recurrence in Papillary Thyroid Carcinoma.
    Jiang LH; Yin KX; Wen QL; Chen C; Ge MH; Tan Z
    Sci Rep; 2020 Jan; 10(1):710. PubMed ID: 31959758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
    Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
    J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Guo JN; Song LH; Yu PY; Yu SY; Deng SH; Mao XH; Xiu C; Sun J
    J Surg Res; 2020 Sep; 253():69-78. PubMed ID: 32335393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning Algorithms for the Prediction of Central Lymph Node Metastasis in Patients With Papillary Thyroid Cancer.
    Wu Y; Rao K; Liu J; Han C; Gong L; Chong Y; Liu Z; Xu X
    Front Endocrinol (Lausanne); 2020; 11():577537. PubMed ID: 33193092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage.
    Zhou B; Wei L; Qin J
    Asian J Surg; 2021 Nov; 44(11):1357-1362. PubMed ID: 33715963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
    Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
    Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
    Li X; Zhang H; Zhou Y; Cheng R
    World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.
    Zhang H; Hu S; Wang X; Liu W; He J; Sun Z; Ge Y; Dou W
    Front Endocrinol (Lausanne); 2020; 11():326. PubMed ID: 32595598
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion.
    Xue S; Zhang L; Pang R; Wang P; Jin M; Guo L; Zhou Y; Dong B; Chen G
    Front Endocrinol (Lausanne); 2020; 11():511. PubMed ID: 33013682
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors of central lymph node metastasis in cN0 papillary thyroid carcinoma: a study of 529 patients.
    Liang K; He L; Dong W; Zhang H
    Med Sci Monit; 2014 May; 20():807-11. PubMed ID: 24831428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F
    Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergic effect of BRAF
    Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
    Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
    Jianming L; Jibin L; Linxue Q
    Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
    Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
    Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
    Seong CY; Chai YJ; Lee SM; Kim SJ; Choi JY; Lee KE; Hwang KT; Park SW; Yi KH
    PLoS One; 2018; 13(7):e0200166. PubMed ID: 30016353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.
    Zhao YZ; He NA; Ye XJ; Jin F; Li MX; Jiang X
    Front Endocrinol (Lausanne); 2022; 13():880911. PubMed ID: 35733781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.